Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2005-6-24
pubmed:abstractText
A SAR study was conducted on chromane-2-carboxylic acid toward selective PPARalpha agonisim. As a result, highly potent, and selective PPARalpha agonists were discovered. The optimized compound 43 exhibited robust lowering of total cholesterol levels in hamster and dog animal models.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3347-51
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15950464-Animals, pubmed-meshheading:15950464-Carboxylic Acids, pubmed-meshheading:15950464-Chromans, pubmed-meshheading:15950464-Cricetinae, pubmed-meshheading:15950464-Dogs, pubmed-meshheading:15950464-Dose-Response Relationship, Drug, pubmed-meshheading:15950464-Drug Design, pubmed-meshheading:15950464-Drug Evaluation, Preclinical, pubmed-meshheading:15950464-Humans, pubmed-meshheading:15950464-Hypolipidemic Agents, pubmed-meshheading:15950464-Macaca mulatta, pubmed-meshheading:15950464-Male, pubmed-meshheading:15950464-Molecular Structure, pubmed-meshheading:15950464-PPAR alpha, pubmed-meshheading:15950464-Rats, pubmed-meshheading:15950464-Rats, Sprague-Dawley, pubmed-meshheading:15950464-Species Specificity, pubmed-meshheading:15950464-Structure-Activity Relationship
pubmed:year
2005
pubmed:articleTitle
(2R)-2-methylchromane-2-carboxylic acids: discovery of selective PPARalpha agonists as hypolipidemic agents.
pubmed:affiliation
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA. hiroo_koyama@merck.com
pubmed:publicationType
Journal Article